The present invention relates to novel compounds according to Formula I or a pharmaceutically acceptable salt thereof wherein the variables are as defined in the claims. The compounds are useful for the treatment of ROR gamma mediated diseases.L'invention concerne des composés représentés par la formule (I), ou un sel pharmaceutiquement acceptable de ceux-ci.